Literature DB >> 22132020

Recurrent mycobacterial infections in a patient with IL-12 deficiency.

Matthew Buckland1, Roshanara Ali, Graham Bothamley, David Lammas, Rainer Doffinger, Hilary Longhurst.   

Abstract

This case of a middle aged woman with IL-12p40 deficiency and recurrent Mycobacterium kansasii infection demonstrates that in vitro sensitivities do not reliably predict the clinical response of non-tuberculous mycobacteria (NTMB), and emphasises the need to exercise caution when reducing treatment intensity in patients with type 1 cytokine defects on the basis of in vitro minimum inhibitory concentration (MIC) data alone.

Entities:  

Year:  2009        PMID： 22132020      PMCID： PMC3028165          DOI： 10.1136/bcr.11.2008.1278

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  10 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 2.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Molecular complementation of IL-12Rbeta1 deficiency reveals functional differences between IL-12Rbeta1 alleles including partial IL-12Rbeta1 deficiency.

Authors:  Esther van de Vosse; Roelof A de Paus; Jaap T van Dissel; Tom H M Ottenhoff
Journal:  Hum Mol Genet       Date:  2005-11-17       Impact factor: 6.150

Review 4.  Nontuberculous mycobacteria.

Authors:  S M Holland
Journal:  Am J Med Sci       Date:  2001-01       Impact factor: 2.378

Review 5.  Genetic dissection of immunity to mycobacteria: the human model.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity.

Authors:  Rainer Döffinger; Matthew R Helbert; Gabriela Barcenas-Morales; Kun Yang; Stephanie Dupuis; Lourdes Ceron-Gutierrez; Clara Espitia-Pinzon; Neil Barnes; Graham Bothamley; Jean-Laurent Casanova; Hilary J Longhurst; Dinakantha S Kumararatne
Journal:  Clin Infect Dis       Date:  2003-12-04       Impact factor: 9.079

7.  Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.

Authors:  Conny Höflich; Robert Sabat; Simone Rosseau; Bettina Temmesfeld; Hortense Slevogt; Wolf-Dietrich Döcke; Gerald Grütz; Christian Meisel; Elke Halle; Ulf B Göbel; Hans-Dieter Volk; Norbert Suttorp
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

Review 8.  Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.

Authors:  R S Witzig; B A Fazal; R M Mera; D M Mushatt; P M Dejace; D L Greer; N E Hyslop
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

9.  Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.

Authors:  J Banks; P A Jenkins
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

10.  Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect.

Authors:  S M Arend; E Cerdá de Palou; P de Haas; R Janssen; M A Hoeve; E M Verhard; T H M Ottenhoff; D van Soolingen; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2004-08       Impact factor: 8.067
  10 in total
  1 in total

1.  Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.

Authors:  Jana P Lovell; Christa S Zerbe; Kenneth N Olivier; Reginald J Claypool; Cathleen Frein; Victoria L Anderson; Alexandra F Freeman; Steven M Holland
Journal:  Ann Am Thorac Soc       Date:  2016-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.